Canceling Supervisory Board

Search documents
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
GlobeNewswire· 2025-06-24 11:30
Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC HOUSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces a comprehensive restructuring of its pre ...
REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis
Prnewswire· 2025-06-24 11:30
Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placeboAchieved statistical significance for key secondary endpoints at week 16 of disease reduction, including EASI-75, EASI-90, Itch NRS, vIGA-AD and BSARapid onset of EASI reduction and magnitude of itch improvement show potential differentiation of this novel regulatory T-cell mechanism as a first and best-in-class immune-modulator Robust dose-depende ...
Constellium Honored with Three Supplier Awards from Airbus
Globenewswire· 2025-06-24 11:30
PARIS, June 24, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) is proud to announce that it has been recognized with three awards at the 2025 edition of Airbus’ Supply Chain & Quality Improvement Program (SQIP), held in early June. The program honors suppliers that consistently deliver excellence in their quality & delivery performance and industrial maturity. Constellium’s facilities in Issoire and Montreuil-Juigné were honored for their significant contributions to Airbus’ supply chain: Issoire – Ac ...
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
Globenewswire· 2025-06-24 11:30
Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medicationsTARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization, to support Good Days’ Retinal Vascular and Neovascular Disease Fund. Through this initiative, Regeneron has committed to matching donations up to a to ...
Parsons Corporation is Ready Now to Build America's Brand New, State Of-The-Art Air Traffic Control System
Globenewswire· 2025-06-24 11:30
CHANTILLY, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Today, Parsons Corporation (NYSE: PSN) and IBM (NYSE: IBM) announced a collaboration to deliver on President Donald Trump’s and Transportation Secretary Sean Duffy’s vision for a brand new, state of-the-art air traffic control system. This collaboration directly responds to Secretary Duffy's call for world-class innovators to rapidly spearhead the overhaul of the Federal Aviation Administration’s (FAA) National Airspace System (NAS), prioritizing an open ven ...
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
Globenewswire· 2025-06-24 11:30
WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025. Mr. Silvestro joined the Company in 2019 and has been the Company’s CEO since March 2025, afte ...
Collegium Pharmaceutical(COLL) - 2021 Q4 - Earnings Call Presentation
2025-06-24 11:29
| --- | --- | --- | |-------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | Q4 and FYE 2021 Earnings Report | | | | February 24, 2022 \| Nasdaq: COLL | | | | --- ...
POET Signs Manufacturing Agreement with NationGate Solutions in Malaysia
Globenewswire· 2025-06-24 11:27
Ships Backlog of 800G Optical Engine Samples to CustomersTORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Corporation”) (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced that it has signed a Master Agreement, Module Purchase Agreement and a Deed of Consignment with NationGate Solutions (M) Sdn. Bhd (“NationGate”), to manufacture optical engin ...
31项!工信部2025国家科技奖候选项目名单公布
机器人圈· 2025-06-24 11:24
详细会议介绍参看往期文章: (点击蓝字跳转) 报名开启|顶流期刊征+2025智能机器人关键技术大会盛会将至! 展览展示|抢位2025智能机器人关键技术大会!高曝光商务合作虚位以待,共赴解锁新机遇 9大期刊联合征文|投稿2025智能机器人关键技术大会,年底正刊发表! 6月21日,工信部发布了关于2025年度国家科学技术奖候选项目的名单。 文章来源:工业和信息化部 封面图源|豆包AI文生图 如需咨询 商务合作、 宣传推广、 转载开白等事宜,请联系:18355423366 (微信同号)对接。 END 75家机器人上市公司2024年报亮点 机器人行业上市公司2024年报出炉!谁领风骚看榜单 55家机器人上市公司2023年报看点:喜忧参半,洗牌加剧 孙立宁院士: 微纳感知赋能具身智能机器人创新发展 浙江大学熊蓉教授: 人形机器人具身智能发展挑战与进展 董凯处长:机器人具身智能发展趋势研判 仿生机器人技术新突破:向松鼠学习跨越复杂地形的智慧 从"破格上市"到市值翻三倍,越疆科技领跑港股机器人赛道 人形机器人量产爆发:价格战火爆来袭,科技革命下的产业重构与社会想象 看点:机器人概念上市公司2024上半年业绩普遍承压,机器人 ...
具身智能测评实验室联合体与职业技能图谱正式发布
机器人圈· 2025-06-24 11:24
北京人形机器人创新中心副总经理李春枝 出席并在研讨会致辞中表示,具身智能作为人工智能与机器人技术融合 的前沿领域,正迎来爆发式发展的关键阶段。技术的突破不仅依赖于算法与硬件的迭代,更需要高质量数据、标 准化测评、场景化应用和专业化人才的协同支撑。本次研讨会聚焦数据、测评、应用、产教四大核心环节,旨在 通过跨界合作,打通技术落地的最后一公里,推动产业生态的加速成型。 会上, 具身智能测评实验室联合体正式揭牌成立 ,旨在解决当前具身智能产业测试指标失真、场景错位、标准真 空的问题,为行业提供一套跨学科、可落地、可迭代的系统化测评能力,作为关键零部件优化、整机迭代及安全 合规的统一 "计量基准"。联合体由北京人形机器人创新中心发起倡议,中国信息通信研究院(信通院)、中国家 用电器研究院(家电院)、中国电器科学研究院(电科院),上电科等权威科研检测机构,山东、浙江、安徽、 湖北等地创新中心携手本地具身智能企业;以及小米、海信,海尔、国家电网、中核自控,京东物流,中国移 动、中国联通,福田康明斯等头部场景应用方,多家领先的人形机器人和 AI 企业共同参与。 实验室联合体发起人,北京人形标准负责人任容玮 介绍未来规划,各 ...